The happy destiny of frozen haematopoietic stem cells: From immature stem cells to mature applications

European Journal of Cancer

Volumn 40, Issue 13, 2004, Pages 1987-1992

  De Vries, E G E ^a   Vellenga, E ^a   Kluin Nelemans, J C ^a   Mulder, N H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Blood; Bone marrow; Haematopoietic stem cells storage; Plasticity; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; DIMETHYL SULFOXIDE; GLYCEROL; POLYVINYL DERIVATIVE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD AUTOTRANSFUSION; BONE MARROW; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER THERAPY; CELL FATE; CELL MATURATION; CELL SPECIFICITY; CELL SUSPENSION; CRYOPRESERVATION; EXPERIMENTAL MOUSE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM TUMOR; HISTORY; MONKEY; NONHUMAN; PERIPHERAL CIRCULATION; PLASTICITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SOLID TUMOR; SPECIES DIFFERENCE; STANDARD; STATISTICAL SIGNIFICANCE; SURVIVAL; TECHNIQUE; TREATMENT INDICATION; UMBILICAL CORD BLOOD;

EID: 4143139770     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.11.040     Document Type: Article

References (28)

1. van Putten L.M. Quantitative aspects of the storage of bone marrow cells for transplantation. Eur. J. Cancer. 1:1965;15-22
2. Thomas E.D., Lochte H.L. Jr., Lu W.C., Ferrebee J.W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. New Engl. J. Med. 257:1957;491-496
3. Santos G.W. Historical background to hematopoietic stem cell transplantation. Atkinson K. Clinical bone marrow and blood stem cell transplantation. 2nd ed.:2000;1-9 Cambridge University Press, New York
4. McFarland W., Granville N.B., Dameshek W. Autologous bone marrow infusion as an adjunct in therapy of malignant disease. Blood. 14:1959;503-521
5. Metcalf D. In vitro cloning of hemopoietic cells. Bull Cancer. 65:1978;417-419
6. Ploemacher R.E., van der Sluijs J.P., Voerman J.S., Brons N.H. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood. 74:1989;2755-2763
7. Thomas E.D. Landmarks in the development of hematopoietic cell transplantation. World J. Surg. 24:2000;815-818
8. Korbling M., Estrov Z. Adult stem cells for tissue repair - a new therapeutic concept? New Engl. J. Med. 349:2003;570-582
9. Szer J. Cryopreservation and assessment of cells. Atkinson K. Clinical bone marrow and blood stem cell transplantation. 2nd ed.:2000;201-207 Cambridge University Press, New York
10. Ossenkoppele G.J., Schuurhuis G.J., et al. G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4°C does support a BEAM-like regimen in bad-risk lymphoma. Bone Marrow Transpl. 18:1996;427-431
11. Spurr E.E., Wiggins N.E., Marsden K.A., Lowenthal R.M., Ragg S.J. Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage. Cryobiology. 44:2002;210-217
12. Tallman M.S., Gray R., et al. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer. New Engl. J. Med. 349:2003;17-26
13. Rodenhuis S., Bontenbal M., et al. Netherlands Working Party on autologous transplantation in solid tumors. High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. New Engl. J. Med. 349:2003;7-16
14. Barker J.N., Wagner J.E. Umbilical-cord blood transplantation for the treatment of cancer. Nat. Rev. Cancer. 3:2003;526-532
15. Broxmeyer H.E., Srour E.F., Hangoc G., Cooper S., Anderson S.A., Bodine D.M. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc. Natl. Acad. Sci. USA. 100:2003;645-650
16. Shimoni A., Korbling M. Tumor cell contamination in re-infused stem cell autografts: does it have clinical significance? Crit. Rev. Oncol. Hematol. 41:2002;241-250
17. Schroder C.P., Kroesen B.J., de Leij L.F., de Vries E.G. Purging of epithelial tumor cells from peripheral blood stem cells by means of the bispecific antibody BIS-1. Clin. Cancer Res. 6:2000;2521-2527
18. Vellenga E., van Agthoven M., et al. Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study. Brit. J. Haematol. 114:2001;319-326
19. Barlogie B., Shaughnessy J.D., Tricot G., et al. Treatment of multiple myeloma. Blood. 103:2004;20-32
20. van Gameren I.I., Hazenberg B.P., Jager P.L., Smit J.W., Vellenga E. AL amyloidosis treated with induction chemotherapy with VAD followed by high dose melphalan and autologous stem cell transplantation. Amyloid. 3:2002;203-206
21. Vellenga E., van Putten W.L., Boogaerts M.A., et al. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia? Bone Marrow Transpl. 23:1999;1279-1282
22. Peters W., Rosner G., et al. A prospective, randomized comparison of two doses of combination alkylating agents (AA) as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes (LN): preliminary results of CALGB 9082/SWOG 9114/NCIC MA-13. Proc. Am. Soc., Clin. Oncol. 18:1999;1a. [abstract]
23. Korbling M., Katz R.L., Khanna A., et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. New Engl. J. Med. 346:2002;738-746
24. Forrester J.S., Price M.J., Makkar R.R. Stem cell repair of infarcted myocardium: an overview for clinicians. Circulation. 108:2003;1139-1145
25. Ivanova N.B., Dimos J.T., Schaniel C., Hackney J.A., Moore K.A., Lemischka I.R. A stem cell molecular signature. Science. 298:2002;601-604
26. Guo Y., Lubbert M., Engelhardt M. CD34-hematopoietic stem cells current concepts and controversies. Stem Cells. 21:2003;15-20
27. Plett P.A., Frankovitz S.M., Orschell-Traycoff C.M. In vivo trafficking, cell cycle activity, and engraftment potential of phenotypically defined primitive hematopoietic cells after transplantation into irradiated or nonirradiated recipients. Blood. 100:2002;3545-3552
28. Mazurier F., Doedens M., Gan O.I., Dick J.E. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat. Med. 9:2003;959-963